New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
09:03 EDTAPTAlpha announces additional $2M expansion of share repurchase program
Alpha Pro Tech announced that its Board of Directors has authorized a $2M expansion of the company’s existing share repurchase program. With this authorized expansion, the company now has approximately $2.1M available to repurchase shares of the company’s common stock, $0.1M of which remains from the previous expansion announced in September 2013. Management anticipates repurchasing shares through open market purchases or through privately-negotiated transactions and intends to retire all shares purchased through the share repurchase program.
News For APT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
10:55 EDTAPTDallas nurse now Ebola virus free, to be released, NBC reports
NBC and other media outlets cites NIH on Nina Pham's release. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED). Reference Link
October 23, 2014
15:25 EDTAPTNew York confirms health care worker being tested for Ebola
Subscribe for More Information
14:58 EDTAPTNew York doctor rushed to hospital with Ebola-like symptoms, NY Post reports
Subscribe for More Information
09:05 EDTAPTAlpha Pro Tech reports Q3 EPS 5c, vs. 5c last year
Subscribe for More Information
06:22 EDTAPTEU to boost Ebola research with EUR 24.4M
The European Commission has today announced EUR 24.4M from the EU budget for urgently needed Ebola research. The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. The money from Horizon 2020, the EU research and innovation program, will be provided via a fast-track procedure in order to start work as soon as possible. The Commission is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola and other haemorrhagic diseases within the Innovative Medicines Initiative. The funding will be provided following proposals from teams across the EU and in numerous 3rd countries, which were evaluated by an independent group of experts. The Commission has also asked the European and Developing Countries Clinical Trials Partnership to include emerging epidemics of concern to Africa, including Ebola, in its work plan. This will allow to fund clinical trials on drugs, vaccines and diagnostics in upcoming calls. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED).
October 22, 2014
06:54 EDTAPTProtection equipment makers see sales rise amid Ebola situation, NY Times says
Subscribe for More Information
October 17, 2014
09:46 EDTAPTSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
October 15, 2014
10:49 EDTAPTEbola linked names rise again amid broader market sell-off
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use